This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Merck & Co., Inc.
Drug Names(s): MK-906
Description: Proscar is a specific inhibitor of steroid Type II5a-reductase, an intracellular enzyme that converts the androgen testosterone into5a-dihydrotestosterone (DHT).
Deal Structure: In August 2006, Astellas withdrew from its partnership with Merck to develop finasteride in Japan.
Pink Sheet Teva Launches Generic Proscar
Additional information available to subscribers only: